glp 1 not obese Weight loss with GLP-1 medicines does result in a disproportionate loss of muscle mass or function in mice and humans Featured in The Week Health

FDAs Decision Delayed by Lawsuit The lawsuit forced the FDA to quickly consider the compounders grievances, and the agency requested a remand to reevaluate its decision on tirzepatides shortage status

Cell Host Microbe 29 , 408424.e7 (2021)

Firstly, researchers observed that GHK-Cu increases MMP-2 levels in the conditioned media of cultured dermal fibroblasts, a process not replicated by GHK alone, suggesting that the presence of copper is posited to be necessary for this activity

The message is consistent: consumer and patient demand remains sky-high, but affordability concerns are forcing payers to rethink their approach